Indaptus Therapeutics, Inc.
INDP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $221 | $414 | $335 | $653 |
| - Cash | $6 | $13 | $10 | $39 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $215 | $401 | $326 | $614 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15 | -$16 | -$15 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$15 | -$15 | -$14 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.61 | -1.84 | -1.73 | -1.89 |
| % Growth | 12.5% | -6.4% | 8.5% | – |
| Operating Cash Flow | -$12 | -$13 | -$13 | -$11 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$12 | -$13 | -$13 | -$11 |